Ashish Bhalla Selected Research

Midodrine (Midon)

1/2017	Midodrine and tolvaptan in patients with cirrhosis and refractory or recurrent ascites: a randomised pilot study.
4/2013	Midodrine and clonidine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
2/2012	Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
6/2008	Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashish Bhalla Research Topics

Disease

21	COVID-19 07/2022 - 01/2020
19	Poisoning 05/2022 - 06/2007
9	Infections 04/2022 - 01/2012
8	End Stage Liver Disease 01/2021 - 06/2007
6	Ascites 08/2022 - 02/2012
6	Fibrosis (Cirrhosis) 01/2021 - 06/2008
5	Hemorrhage 08/2022 - 09/2015
5	Organophosphate Poisoning 05/2022 - 01/2009
4	Scrub Typhus (Typhus, Scrub) 07/2021 - 01/2014
4	Dengue (Dengue Fever) 09/2020 - 02/2010
3	Pancreatitis 05/2022 - 06/2007
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 12/2021 - 01/2016
3	Brain Diseases (Brain Disorder) 09/2020 - 06/2007
3	Neoplasms (Cancer) 01/2020 - 02/2012
3	Malaria 12/2019 - 09/2014
3	Shock 10/2018 - 01/2006
2	Diarrhea 07/2022 - 01/2022
2	Dyspnea (Shortness of Breath) 05/2022 - 06/2019
2	Diabetes Mellitus 04/2022 - 01/2021
2	Pulmonary Embolism 01/2022 - 04/2012
2	Coinfection 01/2022 - 09/2015
2	Abscess 05/2021 - 09/2015
2	Cardiogenic Shock 04/2021 - 01/2006
2	Bites and Stings (Sting) 01/2021 - 01/2010
2	Human Influenza (Influenza) 01/2021 - 01/2012
2	Sepsis (Septicemia) 01/2020 - 10/2019
2	Hemolysis 12/2019 - 07/2004
2	Septic Shock (Toxic Shock Syndrome) 10/2019 - 01/2006
2	Alcoholic Hepatitis 10/2018 - 09/2014
2	Acute Kidney Injury (Acute Renal Failure) 09/2018 - 01/2016
2	Acute Liver Failure (Fulminant Hepatic Failure) 10/2017 - 06/2007
2	Hepatitis 10/2017 - 06/2007
2	Thrombocytopenia (Thrombopenia) 02/2017 - 02/2010
2	Multiple Organ Failure (MODS) 01/2016 - 05/2011
2	Status Epilepticus (Complex Partial Status Epilepticus) 12/2015 - 06/2015
2	Seizures (Absence Seizure) 06/2015 - 01/2014
2	Hepatorenal Syndrome 09/2013 - 06/2012
1	Fever (Fevers) 05/2022
1	Subacute Sclerosing Panencephalitis (SSPE) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Hypertension (High Blood Pressure) 01/2022

Drug/Important Bio-Agent (IBA)

6	OrganophosphatesIBA 05/2022 - 06/2007
5	Anti-Bacterial Agents (Antibiotics)IBA 05/2021 - 07/2018
4	Intravenous Fat EmulsionsIBA 05/2022 - 07/2015
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 09/2014
4	aluminum phosphideIBA 09/2020 - 01/2009
4	Pharmaceutical PreparationsIBA 12/2019 - 06/2015
4	Midodrine (Midon)FDA LinkGeneric 01/2017 - 06/2008
3	Oxygen (Dioxygen)IBA 04/2022 - 09/2021
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2022 - 06/2007
3	VaccinesIBA 01/2022 - 07/2019
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 12/2020
3	AntigensIBA 10/2021 - 01/2014
3	PesticidesIBA 01/2021 - 01/2009
3	AluminumIBA 01/2021 - 01/2013
3	Cytidine Triphosphate (CTP)IBA 11/2018 - 06/2012
2	SteroidsIBA 07/2022 - 02/2010
2	LipidsIBA 05/2022 - 01/2019
2	EmulsionsIBA 05/2022 - 01/2019
2	Amylases FDA Link 05/2022 - 06/2007
2	OximesIBA 01/2022 - 01/2019
2	CholesterolIBA 01/2022 - 01/2003
2	EnzymesIBA 01/2022 - 02/2017
2	Organophosphorus CompoundsIBA 01/2022 - 01/2013
2	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 01/2022 - 04/2012
2	Biomarkers (Surrogate Marker)IBA 07/2021 - 10/2018
2	Methanol (Carbinol)IBA 01/2021 - 12/2019
2	InsecticidesIBA 01/2021 - 01/2019
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021 - 01/2012
2	Retinaldehyde (Retinal)IBA 01/2021 - 04/2003
2	Immunoglobulin M (IgM)IBA 09/2020 - 02/2017
2	Hormones (Hormone)IBA 09/2018 - 01/2015
2	AntioxidantsIBA 12/2017 - 05/2011
2	cyclopropapyrroloindoleIBA 10/2017 - 06/2007
2	SodiumIBA 01/2017 - 09/2013
2	Local AnestheticsIBA 12/2016 - 07/2015
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2014 - 03/2012
2	Vasoconstrictor AgentsIBA 09/2013 - 06/2012
2	TerlipressinIBA 09/2013 - 06/2012
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 09/2013 - 06/2012
2	CreatinineIBA 09/2013 - 06/2007
2	AlbuminsIBA 06/2012 - 06/2008
1	Propranolol (Inderal)FDA LinkGeneric 08/2022
1	Volatile Oils (Essential Oils)IBA 07/2022
1	MouthwashesIBA 01/2022
1	Heparinoids (Heparinoid)IBA 01/2022
1	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2022
1	tocilizumab (atlizumab)FDA Link 12/2021

Therapy/Procedure

16	Therapeutics 01/2022 - 07/2003
9	Length of Stay 07/2022 - 04/2006
5	Artificial Respiration (Mechanical Ventilation) 07/2022 - 01/2016
3	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 09/2018
3	Catheters 11/2020 - 09/2015
3	Critical Care (Surgical Intensive Care) 11/2020 - 02/2014
2	Liver Transplantation 01/2021 - 06/2007
2	Vascular Access Devices (Arterial Line) 11/2020 - 10/2012
2	Central Venous Catheters 11/2020 - 10/2012
2	Resuscitation 01/2020 - 10/2019
2	Renal Dialysis (Hemodialysis) 09/2018 - 01/2016
1	Ligation 08/2022